Iván D. Montoya
Deputy Director of the Division of Therapeutics and Medical Consequences of the National Institute on Drug Abuse of the United States. He is PhD in Medicine and Surgery with a specialization in Psychiatry from the University of Antioquia (Colombia). He obtained a Fulbright scholarship and a Master's degree in Public Health from Johns Hopkins University. He obtained a postdoctoral fellowship in the Intramural Research Program of the National Institute on Drug Abuse. He directs an extensive research program supporting the development of pharmacological and non-pharmacological treatments for substance use disorders. He has published extensively in the areas of etiology, prevention, treatment, and medical consequences of substance abuse.
desenvolupament de medicaments per la FDA

Substance use disorder (SUD) is a significant public health concern. Unfortunately, there are few safe and effective medications to treat SUD and efficacy is suboptimal.